Search
for
Sort by
Research 30 of 68
- Skin disorders in Parkinson’s disease: potential biomarkers and risk factors
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Genetic basis of polycystic ovary syndrome
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review
- Melatonin Receptors and Their Role in Human Diseases
- Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson’s Disease
- Bioinformatic network analysis on the molecular interactions between Parkinson’s disease, alpha-synuclein, and infertility condition
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Polycystic ovary syndrome: a dermatologic approach
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Promoting axonal regeneration through exosomes: An update of recent findings on exosomal PTEN and mTOR modifiers
- Parkinson's disease and skin
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Debatable Topics in PCOS Patients
- TSPO ligand etifoxine attenuates LPS-induced cognitive dysfunction in mice
- Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
- Drugs that affect autonomic functions or the extrapyramidal system
- Syndromes of Severe Insulin Resistance (SSIRs)
- Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease
- Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
- In This Issue
- SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms
- Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases
- Possible contribution of chronobiology to cardiovascular health
- The metabolic syndrome in children and adolescents
- Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models